Prudential PLC Acquires 1,498 Shares of The Cigna Group (NYSE:CI)

Prudential PLC increased its holdings in The Cigna Group (NYSE:CIFree Report) by 7.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 20,443 shares of the health services provider’s stock after buying an additional 1,498 shares during the period. Prudential PLC’s holdings in The Cigna Group were worth $6,122,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CI. AdvisorShares Investments LLC purchased a new stake in shares of The Cigna Group during the 4th quarter valued at $444,000. CenterBook Partners LP raised its position in shares of The Cigna Group by 48.7% during the 4th quarter. CenterBook Partners LP now owns 5,362 shares of the health services provider’s stock valued at $1,606,000 after buying an additional 1,756 shares in the last quarter. Platform Technology Partners raised its position in shares of The Cigna Group by 27.0% during the 4th quarter. Platform Technology Partners now owns 1,177 shares of the health services provider’s stock valued at $352,000 after buying an additional 250 shares in the last quarter. Epoch Investment Partners Inc. raised its position in shares of The Cigna Group by 2.8% during the 4th quarter. Epoch Investment Partners Inc. now owns 2,690 shares of the health services provider’s stock valued at $806,000 after buying an additional 74 shares in the last quarter. Finally, Vinva Investment Management Ltd raised its position in shares of The Cigna Group by 17.2% during the 4th quarter. Vinva Investment Management Ltd now owns 10,217 shares of the health services provider’s stock valued at $3,059,000 after buying an additional 1,498 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

Insider Activity

In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the company’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $348.71, for a total transaction of $2,073,429.66. Following the completion of the sale, the senior vice president now directly owns 2,595 shares of the company’s stock, valued at $904,902.45. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the company’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $348.71, for a total value of $2,073,429.66. Following the completion of the transaction, the senior vice president now directly owns 2,595 shares in the company, valued at $904,902.45. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO David Cordani sold 6,338 shares of the company’s stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $355.11, for a total transaction of $2,250,687.18. Following the completion of the transaction, the chief executive officer now owns 348,054 shares of the company’s stock, valued at $123,597,455.94. The disclosure for this sale can be found here. Insiders sold 67,954 shares of company stock valued at $23,916,855 over the last three months. Insiders own 0.60% of the company’s stock.

The Cigna Group Stock Up 0.1 %

Shares of NYSE CI traded up $0.19 during midday trading on Friday, hitting $338.10. The stock had a trading volume of 1,208,098 shares, compared to its average volume of 1,800,601. The business’s 50 day moving average is $346.91 and its 200-day moving average is $326.44. The company has a market cap of $96.04 billion, a P/E ratio of 27.76, a PEG ratio of 1.03 and a beta of 0.53. The Cigna Group has a 52 week low of $253.95 and a 52 week high of $365.71. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.75.

The Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Thursday, May 2nd. The health services provider reported $6.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.17 by $0.30. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The firm had revenue of $57.25 billion for the quarter, compared to the consensus estimate of $56.59 billion. During the same quarter in the prior year, the firm posted $5.41 earnings per share. The business’s revenue was up 23.2% on a year-over-year basis. As a group, analysts predict that The Cigna Group will post 28.47 EPS for the current year.

The Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 20th. Stockholders of record on Tuesday, June 4th will be issued a dividend of $1.40 per share. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a $5.60 annualized dividend and a dividend yield of 1.66%. The Cigna Group’s payout ratio is 45.98%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on CI. StockNews.com cut shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 3rd. Baird R W upgraded shares of The Cigna Group to a “strong-buy” rating in a research report on Thursday, May 30th. Cantor Fitzgerald boosted their price objective on shares of The Cigna Group from $384.00 to $400.00 and gave the company an “overweight” rating in a research report on Friday, May 3rd. Morgan Stanley restated an “overweight” rating and issued a $392.00 price objective (up previously from $382.00) on shares of The Cigna Group in a research report on Monday, March 4th. Finally, Barclays started coverage on shares of The Cigna Group in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $393.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, The Cigna Group currently has a consensus rating of “Buy” and a consensus target price of $373.87.

Get Our Latest Research Report on CI

The Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.